T. Rowe Price holds 9.87M shares of Shattuck Labs (NASDAQ: STTK) amendment
Rhea-AI Filing Summary
Shattuck Labs Inc. ownership filing reports that T. Rowe Price Investment Management, Inc. holds 9,865,558 shares of common stock, representing 13.8% of the class as shown for the period 03/31/2026. The filer states sole voting power for 9,831,415 shares and sole dispositive power for 9,865,558 shares. The filing is an amendment and is signed by a Vice President on 05/15/2026.
Positive
- None.
Negative
- None.
Insights
T. Rowe Price reports a sizable 13.8% stake in STTK as of 03/31/2026.
The filing shows 9,865,558 shares beneficially owned with sole voting power on 9,831,415 shares, indicating control over voting for most of the position. This is a passive ownership disclosure typical for large institutional holders.
Cash‑flow treatment or planned transactions are not disclosed here; subsequent amendments or Schedule 13D would show active changes if they occur.
The Schedule 13G/A is an amendment confirming reported beneficial ownership and voting/dispositive details.
The form lists the issuer CUSIP 82024L103 and identifies the filer as a Maryland entity. It includes explicit counts for voting and dispositive power, which matter for regulatory thresholds and reporting obligations.
Any change above reporting thresholds would require further amendment; monitor future filings for shifts in percent ownership or change in voting status.
Key Figures
Key Terms
Schedule 13G/A regulatory
Beneficial ownership regulatory
Sole dispositive power regulatory
CUSIP technical
AI-generated analysis. How Rhea-AI works. Not financial advice.